Results 171 to 180 of about 53,966 (218)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy

Ophthalmology and Eye Diseases, 2013
We evaluated the effect of intravitreal bevacizumab (IVB) injection before pars plana vitrectomy (PPV) on intravitreal hemorrhage (VH) during and after vitrectomy for postoperative the first day and the first month in pseudophakic patients with ...
Ersin Oba, Efe Can
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Intravitreal Bevacizumab for Retinopathy of Prematurity

Journal of Ocular Pharmacology and Therapeutics, 2011
To evaluate the therapeutic effect of a single intravitreal injection of bevacizumab for treatment of threshold retinopathy in retinopathy of prematurity (ROP).The retrospective study consisted of all infants who developed threshold ROP in fundus zone I or zone II and who consecutively received an intravitreal injection of bevacizumab (0.375 mg, 0.03 ...
Björn C, Harder, Stefan, von Baltz, Jost B, Jonas, Frank C, Schlichtenbrede   +3 more
openaire   +2 more sources

INTRAVITREAL BEVACIZUMAB DURING PREGNANCY

Retina, 2010
To report the clinical course of four women treated with intravitreal bevacizumab during pregnancy.Observational case series.Four pregnant women were treated with intravitreal bevacizumab for choroidal neovascularization (CNV) because of presumed ocular histoplasmosis syndrome punctate inner choroidopathy, or sarcoid uveitis.
Ryan M, Tarantola, James C, Folk, H Culver, Boldt, Vinit B, Mahajan   +3 more
openaire   +2 more sources

Intravitreal Bevacizumab for Diabetic Papillopathy

Journal of Ocular Pharmacology and Therapeutics, 2010
A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect.
Örnek, Kemal, Oğurel, Tevfik
openaire   +3 more sources

Intravitreal Bevacizumab for Diabetic Retinopathy

Current Diabetes Reviews, 2009
Diabetic retinopathy (DR) remains the major threat to sight in the working age population. Diabetic macular edema (DME) is a manifestation of DR that produces loss of central vision. Macular edema within 1 disk diameter of the fovea is present in 9% of the diabetic population.
J Fernando, Arevalo, Rafael A, Garcia-Amaris   +1 more
openaire   +2 more sources

Intravitreal Bevacizumab for Incontinentia Pigmenti

Journal of Pediatric Ophthalmology & Strabismus, 2013
Two eyes of two siblings affected with incontinentia pigmenti having severe proliferative retinopathy are reported. Both cases showed complete resolution of new vessels after a single injection of intravitreal bevacizumab. At 7 months of follow-up, the first case revealed vascularization to the mid-periphery including a vascularized fovea (
Parag K, Shah, Sandeep, Bachu, Venkatapathy, Narendran, Narendran, Kalpana, Jeevamala, David, Chakravarthi R, Srinivas   +5 more
openaire   +2 more sources

Pharmacokinetics of Intravitreal Bevacizumab (Avastin)

Ophthalmology, 2007
To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin).Experimental animal study.Twenty Dutch-belted rabbits.One eye of each of 20 rabbits was injected with 1.25 mg of intravitreal bevacizumab. Both eyes of each of 4 rabbits were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentrations were measured in aqueous fluid,
Sophie J, Bakri, Melissa R, Snyder, Joel M, Reid, Jose S, Pulido, Ravinder J, Singh   +4 more
openaire   +2 more sources

Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization

American Journal of Ophthalmology, 2008
To assess the role of bevacizumab in inflammatory ocular neovascularization.Retrospective, multicenter, consecutive case series of inflammatory ocular neovascularization.Patients with inflammatory ocular neovascularization of varying causes for whom standard therapy failed were treated with intravitreal injection of bevacizumab.
Ahmad M, Mansour, Friederike, Mackensen, J Fernando, Arevalo, Focke, Ziemssen, Padmamalini, Mahendradas, Abla, Mehio-Sibai, Nicholas, Hrisomalos, Timothy Y Y, Lai, David, Dodwell, Wai-Man, Chan, Thomas, Ness, Alay S, Banker, Sivakami A, Pai, Maria H, Berrocal, Rania, Tohme, Arnd, Heiligenhaus, Ziad F, Bashshur, Moncef, Khairallah, Khalil M, Salem, Frank N, Hrisomalos, Matthew H, Wood, Wilson, Heriot, Alfredo, Adan, Atul, Kumar, Lyndell, Lim, Anthony, Hall, Matthias, Becker   +26 more
openaire   +3 more sources

Angioedema after intravitreal bevacizumab injection

Cutaneous and Ocular Toxicology, 2012
A 47-year-old male with a history of diabetes mellitus type 2 exhibited with decreased vision in both eyes. The diagnosis of cystoid macular edema (CME) was made and it was decided to administer bilateral intravitreal bevacizumab (Avastin) injections. After intravitreal bevacizumab injection (1.25 mg/0.05 cc) to the right eye the patient had angioedema
Yasin, Toklu, Ozge, Sarac, Sule, Berk, Saban, Simsek   +3 more
openaire   +2 more sources

Silicone oil droplets following intravitreal bevacizumab injections

American Journal of Ophthalmology Case Reports, 2018
Purpose: To report the transient resurgence of symptomatic silicone oil droplets following intravitreal bevacizumab injections. Observations: We report seven patients presenting with silicone oil droplets following intravitreal bevacizumab injections ...
Esmeralda Gallemore, Jea H Yu, Ron P Gallemore   +2 more
exaly   +2 more sources